Lisata Therapeutics, Inc. Gains 38.39%

Fri, Aug 21, 2026 at 07:29 PM

Lisata Therapeutics, Inc. (LSTA:NASDAQ) jumped higher at $1.55, a gain of 38.4%. On Fri, Aug 21, 2026, LSTA:NASDAQ touched a New 2-Week High of $1.55. The stock appeared on our News Catalysts scanner on Thu, Aug 13, 2026 at 03:17 AM in the 'INVESTOR UPDATE' category. From Fri, Aug 07, 2026, the stock recorded 40.00% Up Days and 36.36% Green Days

About Lisata Therapeutics, Inc. (LSTA:NASDAQ)

Caladrius Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to the development of treatments and reversal of severe diseases.

Top 10 Gainers:

RF Acquisition Corp II (RFAI:NASDAQ), 355.62%
Werewolf Therapeutics, Inc. (HOWL:NASDAQ), 102.57%
StablecoinX Inc. (USDE:NASDAQ), 85.25%
KNOREX LTD. Class A (KNRX:NYSEMKT), 57.58%
Sadot Group Inc. (SDOT:NASDAQ), 56.16%
AIAI Holdings Corporation (AIAI:NASDAQ), 46.14%
Exyn Technologies Inc. (EXYN:NASDAQ), 39.87%
Lisata Therapeutics, Inc. (LSTA:NASDAQ), 38.39%
The9 Limited (NCTY:NASDAQ), 32.57%
Cango Inc. (CANG:NYSE), 32.1%